Viveve Medical (VIVE) Receives Approval for Viveve System in U.A.E., Lebanon
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Viveve Medical, Inc. (Nasdaq: VIVE) announced that the company has received regulatory approvals for the Viveve System in the United Arab Emirates (U.A.E.) and Lebanon. The Viveve System is now cleared for marketing in 47 countries throughout the world.
"U.A.E. and Lebanon represent very important markets for Viveve and the regulatory approvals of the Viveve System in these countries are significant developments. In partnership with our distribution partner, Medica Group, we have begun the commercialization efforts for the Viveve System in the Middle East to make this clinically-proven treatment available to women in the region whose quality of life is impacted by vaginal laxity," said Patricia Scheller, chief executive officer of Viveve.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Felcor Lodging Trust (FCH) Receives Letter from Snow Park Capital; Calls for Evaluation of Strategic Alternatives
- SeaSpine Holdings (SPNE) Reports FDA 510(k) Clearance of Shoreline ACS System
- Oceaneering (OII) Receives Two-Year FSVS Contract Extension from BP (BP) Unit for Offshore Angola Work
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!